Dr. Khalessi specializes in cranial and endovascular neurosurgery.
Dr. Khalessi graduated from Stanford University with departmental honors in public policy and master’s of science training in health services research. After earning his medical degree at the Johns Hopkins School of Medicine, Khalessi completed his neurosurgical residency at the University of Southern California and completed the internationally recognized endovascular neurosurgery fellowship with Dr. Nick Hopkins at SUNY Buffalo. He comes to UC San Diego after expanding the endovascular neurosurgery service as a Clinical Instructor at LAC and USC.
Khalessi holds several national leadership positions in both graduate medical education and the treatment of cerebrovascular disease. He serves as a member of the Residency Review Committee for Neurosurgery and Editorial Board for the Journal of Graduate Medical Education. Khalessi was further named to the ACGME Working Group for Neurosurgical Milestones that will define the national standards of neurosurgical training.
Within his subspecialty, Khalessi is a member AANS/CNS Joint Clinical Guidelines Committee that defines clinical practice standards, Executive Committee of the Joint AANS/CNS Cerebrovascular Section, and is principal editor of a free standing Ischemic Stroke Supplement for World Neurosurgery, the official Journal of the World Federation of Neurosurgical Societies.
Khalessi’s research interests include open surgical and endovascular therapies for intracranial aneurysms, large-vessel ischemic stroke, and intensive care management and prognosis in head injury.
Areas of Expertise (7)
CMS Stage 1 EHR
Johns Hopkins School of Medicine: M.D.
University of Southern California: Residency
SUNY Buffalo: Fellowship
- SUNY Buffalo School of Medicine
- University of Southern California - LAC+USC Medical Center
- Johns Hopkins School of Medicine
Media Appearances (3)
What It’s Like to Live for 15 Years After a Stroke
Health Line online
There’s been a massive change in stroke care in the last five years,” Alexander A. Khalessi, chairman of neurological surgery at the University of California San Diego Health, told Heathline...
Trial results signal big shift for stroke care
The San Diego Union-Tribune
Dr. Alexander Khalessi, chairman of neurological surgery at UC San Diego which, along with Scripps Memorial Hospital La Jolla, was among the 38 facilities nationwide selected to participate in the trial, said that brain imaging and analysis is now good enough to determine which parts of the brain have already died and which are at risk of death due to slower blood flow.
“We’re using a selection criteria of 1.8 which means that, if the area of the brain that’s at risk is at least 1.8 times larger than the area that has already died, then it’s safe to remove the clot even it has been in place for longer than six hours,” Khalessi said...
National search leads UC San Diego tapping Dr. Alexander Khalessi as neurosurgery chair
Beckers Spine online
UC San Diego Health selected Alexander Khalessi, MD, to serve as its neurosurgery chair. He will also serve as chief of neurosurgery at UC San Diego School of Medicine...
Spiotta, Alejandro M. et al.
No conventional surgical intervention has been shown to improve outcomes for patients with spontaneous intracerebral hemorrhage (ICH) compared with medical management.
Levy, Elad I., et al.
Although early data demonstrate encouraging angiographic results following intracranial stent deployment for acute ischemic stroke, longer-term follow-up is necessary to evaluate the clinical outcomes, as well as the durability of angiographic results.
Samdani, Amer F., et al.
The following review of the literature describes the ganglioglioma, an uncommon mixed glioneuronal neoplasm, most often of low-grade histology, with a small, albeit well-documented, malignant potential. These tumors exhibit a strong epileptogenic propensity and most often present as new onset seizures or are discovered after a long history of refractory epilepsy. Despite their indolent course, the importance of gross total resection is well recognized to prevent anaplastic and malignant degeneration. Morphologically, the neoplasm is often cystic with an enhancing mural nodule, but can also be entirely solid. They are most often found in the temporal lobe but have been found throughout the neuraxis. An exceedingly rare location of the ganglioglioma is within the lateral ventricle. A systematic literature search revealed only eight reports documenting the occurrence of a ganglioglioma within the lateral ventricle. We describe an illustrative case of an intraventricular ganglioglioma with a prominent cystic component and enhancing mural nodule, which represents the classic radiographic appearance of gangliogliomas described in other locations. A superior parietal lobule approach offered excellent surgical access for tumor removal and the patient has remained free of neurological deficits following surgery. Regardless of location within the central nervous system, ganglioglioma should be on the differential diagnosis for any cystic mass with a mural nodule, particularly in the setting of epilepsy.
Zada, Gabriel, et al.
A fetal variant posterior cerebral artery (fetal PCA) is an embryological remnant in which the PCA is primarily supplied via the anterior cerebral circulation. Internal carotid artery (ICA) aneurysms originating from the takeoff of fetal PCA vessels deserve special attention before surgical or endovascular obliteration because of a greater potential for ischemic injury. We present the first series of ICA-posterior communicating artery (PComA) aneurysms originating at the takeoff of fetal PCA vessels that were treated by surgical or endovascular intervention.
North, Richard B., et al.
Internally powered, implanted pulse generators (IPGs) have been an important advance in spinal cord stimulation for the management of pain, but they require surgical replacement, with attendant cost and risk, when the implanted battery is depleted. Battery life is determined by the programmed settings of the implant, but until now the technical means to optimize settings for maximal battery life, delaying surgical replacement as long as possible.